Non-Myeloablative Allogeneic Transplantation

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Surgery
Cover of the book Non-Myeloablative Allogeneic Transplantation by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461509196
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461509196
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.

More books from Springer US

Cover of the book Biomedical Science and Technology by
Cover of the book Acquired Immunodeficiency Syndrome by
Cover of the book Information Hiding: Steganography and Watermarking-Attacks and Countermeasures by
Cover of the book Biophysical Chemistry of Proteins by
Cover of the book Endometrial Cytology with Tissue Correlations by
Cover of the book Ultra-Wideband and 60 GHz Communications for Biomedical Applications by
Cover of the book Purchasing and Supply Management by
Cover of the book Advances in Modelling and Clinical Application of Intravenous Anaesthesia by
Cover of the book Evolutionary Algorithms and Agricultural Systems by
Cover of the book Elderly People and the Environment by
Cover of the book Reasoning in Boolean Networks by
Cover of the book Clinical Disorders of Memory by
Cover of the book Design Research in Information Systems by
Cover of the book Randomised Controlled Clinical Trials by
Cover of the book Wavelets by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy